SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 63 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $7,000 | -91.1% | 13,486 | -90.7% | 0.00% | – |
| Q1 2016 | $79,000 | -43.2% | 145,557 | -6.0% | 0.00% | – |
| Q4 2015 | $139,000 | +15.8% | 154,773 | +4.5% | 0.00% | – |
| Q3 2015 | $120,000 | -73.8% | 148,091 | -2.6% | 0.00% | – |
| Q2 2015 | $458,000 | -87.3% | 152,003 | -89.7% | 0.00% | -100.0% |
| Q1 2015 | $3,611,000 | +2.6% | 1,473,843 | +6.8% | 0.00% | 0.0% |
| Q4 2014 | $3,518,000 | -58.5% | 1,379,779 | +16.2% | 0.00% | -50.0% |
| Q3 2014 | $8,479,000 | +8.4% | 1,187,555 | -1.0% | 0.00% | 0.0% |
| Q2 2014 | $7,820,000 | +14.4% | 1,199,361 | +15.9% | 0.00% | 0.0% |
| Q1 2014 | $6,838,000 | +65.3% | 1,034,564 | +18.5% | 0.00% | +100.0% |
| Q4 2013 | $4,137,000 | -8.6% | 872,732 | -4.3% | 0.00% | -50.0% |
| Q3 2013 | $4,524,000 | +8.2% | 912,178 | +13.1% | 0.00% | 0.0% |
| Q2 2013 | $4,182,000 | – | 806,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 1,320,000 | $9,425,000 | 10.46% |
| RA Capital Management | 4,869,261 | $34,767,000 | 4.11% |
| GREAT POINT PARTNERS LLC | 400,000 | $2,856,000 | 1.23% |
| Healthcare Value Capital, LLC | 100,000 | $714,000 | 0.69% |
| DSC Advisors, L.P. | 175,000 | $1,250,000 | 0.63% |
| Quantitative Systematic Strategies LLC | 107,416 | $803,000 | 0.47% |
| Visium Asset Management, LP | 4,093,890 | $29,230,000 | 0.43% |
| Rhenman & Partners Asset Management AB | 201,171 | $1,436,000 | 0.42% |
| EAM Investors, LLC | 277,807 | $1,984,000 | 0.40% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 354,861 | $2,534,000 | 0.39% |